EUS-directed transgastric ERCP (EDGE) is an effective minimally invasive technique for ERCP in patients with Roux-en-Y gastric bypass (RYGB), though adverse events such as lumen-apposing metal stent (LAMS) displacement may occur¹. We report a 69-year-old patient with RYGB and obstructive jaundice due to choledocholithiasis who underwent EDGE. ERCP achieved complete bile duct clearance, but LAMS displacement occurred during scope withdrawal, resulting in loss of anastomotic continuity. Endoscopic removal of the displaced stent and peritoneal navigation allowed successful deployment of a new LAMS, restoring the anastomosis. No delayed adverse events occurred. This case highlights the role of advanced endoscopic management in resolving complex EDGE-related complications and avoiding surgery.